Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Dec 23, 2024 6:43pm
RE:RE:RE:Epidiolex ANDA.
LOL! , I'm aware Jazz settled with most Litigants, this Corp don't share squat...definitely won't hear anything until launch....I don't think the FDA would do a 5 day site inspection
...more
(5)
•••
MartianMarvin
X
View Profile
View Bullboard History
Comment by
MartianMarvin
on Dec 23, 2024 1:53pm
RE:RE:Epidiolex ANDA.
What's this nonsense you're chattering on about again Butter? You think that a delay of days or weeks means something with this....lol..... A bunch of litigants settled, the partner of
...more
(141)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Dec 23, 2024 11:25am
Speculation
Since Mr. Pidduck is there speculation has been on the air and nothing has been realized, almost 2 years now and the stock keep his historic low at $0,06 oh he said the stock worth $0,15 so he is not
...more
(86)
•••
corvette67
X
View Profile
View Bullboard History
Post by
corvette67
on Dec 23, 2024 10:40am
out
Sold last 100k, all being traded on other exchanges. Now it can go up for you,. Good luck and best wishes.
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Dec 22, 2024 10:56pm
Comparable.
Brain bio, similar business to MPL, similar assets/revenue, debt free, trading in euros..market cap converted into cdn, 123m...if labs had the same valuation fully diluted we would sit at .28c share..
...more
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Dec 22, 2024 9:55pm
RE:Epidiolex ANDA.
Interestingly, typo, Abbreviated New Drug Application (ANDA) submitted to the FDA in September 2023 ...should read 2022..furthermore..Jazz did not file suit until January 3rd 2023. ANDA
...more
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Dec 22, 2024 9:30pm
Epidiolex ANDA.
US FDA Status Update MediPharm completed a US FDA five day in-person inspection from November 21 to 25, 2022. This was initiated in relation to MediPharm’s Cannabidiol Active Pharmaceutical
...more
(56)
•••
Macpoor
X
View Profile
View Bullboard History
Comment by
Macpoor
on Dec 21, 2024 2:50pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
Thank you@ Marvin! You might have an answer to my second question@ Why do combined income for both Vivo and LABS under 10 million? I am from Vivo .I remembered Vivo@s income was around 7 or 8 million
...more
(56)
•••
Macpoor
X
View Profile
View Bullboard History
Comment by
Macpoor
on Dec 21, 2024 2:42pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
Thank you Marvin! You might have an answer to my second question Why do combined income for both Vivo and LABS under 10 million? I am from Vivo .I remembered Vivo's income was around
...more
(94)
•••
Solid1
X
View Profile
View Bullboard History
Post by
Solid1
on Dec 21, 2024 11:59am
Against the machine
Here is another evaluation of studies carried out in Germany that looks very promising https://www.dgschmerzmedizin.de/news/dgs-pressemitteilungen/detail/news/dgs-schmerzinitiative-fuer-eine
...more
(94)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Dec 20, 2024 1:26pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
Ontario Cornering…. :-D
(94)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Dec 20, 2024 1:21pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
The last one should probably be convinced to sell here... he'll be taken over soon anyway :-D as far as the share purchases and sales are concerned, it was probably more left pocket right pocket
...more
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Dec 20, 2024 11:44am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
How many shares have traded hands over the past two years? 300m?..in the .06-10c range..I wouldn't be happy but a bid at 14c would easily pass..not to mention retailers are never bothered to vote.
...more
(5)
•••
MartianMarvin
X
View Profile
View Bullboard History
Comment by
MartianMarvin
on Dec 20, 2024 11:27am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
LABS doesn't need any more partners? Have you seen topline lately? lol.....Stada isn't blowing numbers out of the water and any other channel can be seen as anemic as they..... ps
...more
(223)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Dec 20, 2024 9:43am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.
MPL doesn't need more partners, disclosed; Avicanna, Stada, "global pharmaceutical Corp"(ANDA), "top three largest Brazilian pharmaceutical Corp", Ketania health..20m
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.